home / stock / allr / allr news

ALLR News and Press, Allarity Therapeutics Inc. From 05/02/24

Stock Information
Company Name: Allarity Therapeutics Inc.
Stock Symbol: ALLR
Market: NASDAQ
Website: allarity.com
Menu
ALLR ALLR Quote ALLR Short ALLR News ALLR Articles ALLR Message Board
Get ALLR Alerts

News, Short Squeeze, Breakout and More Instantly...
ALLR - Allarity rallies on conclusion of mid-stage trial for its ovarian cancer treatment after showing clinical benefit

2024-05-02 09:01:39 ET More on Allarity Therapeutics Allarity Therapeutics receives Nasdaq-approved extension to regain compliance Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial inform...
ALLR - Allarity Therapeutics' Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the early discontinuation of its Phase 2 clinical tri...

ALLR - Allarity regains compliance with NASDAQ minimum bid price requirement

2024-04-29 09:21:40 ET More on Allarity Therapeutics Allarity Therapeutics receives Nasdaq-approved extension to regain compliance Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial inform...

ALLR - Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement

Boston (April 29, 2024) — Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that on April 27, 2024, it received formal notic...
ALLR - Predictive Oncology, BIMI Holdings, IMAC Holdings among healthcare movers

2024-04-19 10:00:25 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Short interest in S&P 500 health stocks rises, Moderna among m...

ALLR - Allarity Therapeutics receives Nasdaq-approved extension to regain compliance

2024-04-17 09:19:37 ET More on Allarity Therapeutics Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial information for Allarity Therapeutics Read the full article on Seeking Alpha ...

ALLR - Allarity Therapeutics Receives NASDAQ-Approved Extension to Regain Compliance with Nasdaq Listing Rule 5550(b)(1)

Boston (April 17, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced that it had been granted an extension until May 14...
ALLR - WIRE, CUTR and USEG are among premarket gainers

2024-04-15 08:41:18 ET More on premarket gainers & stock Carvana, Vroom, BuzzFeed, Encore Wire - Getting Paid To Take Risks With Courage & Conviction Investing U.S. Energy Corp. (USEG) Q4 2023 Earnings Call Transcript Cutera, Inc. (CUTR) Q4 2023 Earnings Call...

ALLR - Allarity Therapeutics Inc. (NASDAQ: ALLR) Near the Top of Equities by Percentage Gain on 4/12

Allarity Therapeutics Inc (NASDAQ: ALLR) is one of today's top gainers. The company's shares have moved 20.87% on the day to $2.78. Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics gen...

ALLR - US Companies Moving the Markets, Morning edition
Fri, Apr 12, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Beneficient (BENF) rose 44.7% to $0.1 on volume of 79,601,246 shares PaxMedica Inc. (PXMD) rose 123.0% to $0.9183 on volume of 54,446,384 shares NextPlat Corp (NXPL) rose 40.0% to $2.1 on volume of 30,284,097 shares Direxion Daily S...
Previous 10 Next 10